A pharmacogenetic study implicates NINJ2 in the response to Interferon-ß in multiple sclerosis

- Peroni, Silvia, Sorosina, Melissa, Álvarez-Cermeño, José Carlos, Guaschino, Clara, Radaelli, Marta, Citterio, Lorena, Lechner-Scott, Jeannette, Spataro, Nino, Navarro, Arcadi, Martinelli, Vittorio, Montalban, Xavier, Weiner, Howard L., Malhotra, Sunny, de Jager, Philip, Comi, G, Esposito, F, Comabella, M, Martinelli-Boneschi, F, Clarelli, Ferdinando, Osiceanu, Ana Maria, Ferrè, Laura, Roostaei, Tina, Rio, Jordi, Midaglia, Luciana, Villar, Luis Maria

NLRP3 polymorphisms and response to interferon-beta in multiple sclerosis patients

- Malhotra, Sunny, Sorosina, Melissa, Zettl, Uwe K., Lechner-Scott, Jeannette, Spataro, Nino, Navarro, Arcadi, Comi, Giancarlo, Montalban, Xavier, Martinelli-Boneschi, Filippo, Comabella, Manuel, Río, Jordi, Peroni, Silvia, Midaglia, Luciana, Villar, Luisa M., Álvarez-Cermeño, Jose C., Schroeder, Ina, Esposito, Federica, Clarelli, Ferdinando

Genetic variants are major determinants of CSF antibody levels in multiple sclerosis

- Goris, An, Pauwels, Ine, D'Alfonso, Sandra, Barizzone, Nadia, Leone, Maurizio A., Boneschi, Filippo Martinelli, Sorosina, Melissa, Liberatore, Giuseppe, Kockum, Ingrid, Olsson, Tomas, Hillert, Jan, Alfredsson, Lars, Gustavsen, Marte W., Lechner-Scott, Jeannette, van Son, Brechtje, Hilven, Kelly, Bos, Steffan D., Celius, Elisabeth Gulowsen, Berg-Hansen, Pål, Aarseth, Jan, Myhr, Kjell-Morten